⌘K

Login Start Free

Home/Filings/4/0001127602-23-020952

4//SEC Filing

Douglas Robert Andrew 4

Accession 0001127602-23-020952

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 5:02 PM ET

Size

5.1 KB

Accession

0001127602-23-020952

Insider Transaction Report

Form 4

Period: 2023-07-17

Douglas Robert Andrew

COO Asia Pacific

Transactions

Sale
ResMed Common Stock
2023-07-17$222.22/sh−1,500$333,330→ 252,026 total(indirect: By Trust)

Holdings

ResMed Common Stock
16,874

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001352232

Filing Metadata

Form type: 4
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 5:02 PM ET
Size: 5.1 KB

View on SEC.gov